StockData
VOGXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Vogenx, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Sep 17, 2026
$15.92+1.39 (+9.57%)

Close on Oct 19, 2026

Market cap
$86.79M
P/E (TTM)
–
Dividend yield
–

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Vogenx has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Vogenx filed with the SEC